secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001842952-25-000085
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics receives Nasdaq extension until Feb 23, 2026 for bid price compliance
--------------------------------------------------------------------------------

- Received Nasdaq extension letter on Aug 28, 2025; new compliance deadline Feb 23, 2026.
- Originally notified of non-compliance on Feb 27, 2025; need $1.00 closing bid for 30 consecutive days.
- Company may consider reverse stock split to regain bid price compliance.
- Listing and trading of CNTX common stock unaffected by extension letter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295225000085/0001842952-25-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295225000085/cntx-20250828.htm
  HTML page:      https://secwatch.observer/filing/0001842952-25-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer